11.99
01-May-25 16:45:00
15 minutes delayed
Stocks
+0.20
+1.70%
Today's range
11.21 - 12.26
ISIN
N/A
Source
NASDAQ
Dyne Therapeutics Myotonic Dystrophy Type 1 Program Achieves Robust RNA Knock Down of Toxic Human Nuclear DMPK in Preclinical Study
10 Jan 2021 15:00:00 By Nasdaq GlobeNewswire
Dyne Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference
05 Jan 2021 07:30:00 By Nasdaq GlobeNewswire